The Expression of Cyclooxygenase-2 and Survivin in Urinary Bladder Transitional Cell Carcinoma
Àå¼®¿ë, ÀÌ°æ¼·,
¼Ò¼Ó »ó¼¼Á¤º¸
Àå¼®¿ë ( Jang Suk-Yong )
µ¿±¹´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
ÀÌ°æ¼· ( Lee Kyung-Seob )
µ¿±¹´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
KMID : 0357920090430030206
Abstract
Background: The aim of this study was to investigate the expressions of cyclooxygenase-2 (COX-2) and survivin in bladder transitional cell carcinoma (TCC) that has different clinicopathologic characteristics, and we also wanted to determine if a relation exists between the COX-2 and survivin expressions.
Methods: The expressions of COX-2 and survivin were investigated in 80 bladder TCCs by performing immunohistochemistry.
Results: The normal bladder mucosa did not express COX-2 and survivin. COX-2 immunopositivity and cytoplasmic survivin immunopositivity were seen in 48% and 30% of bladder tumors, respectively. The expressions of COX-2 and survivin were closely related to the differentiation, depth and recurrence of bladder TCC, and there was a significant correlation in topographic distribution of COX-2 and survivin immunopositivity. In addition, COX-2 and survivin were predominantly expressed at the invasive front of tumors.
Conclusions: This data suggest that COX-2 and survivin may be involved in the progression of bladder TCC, and there is a close correlation between the expressions of COX-2 and survivin.
Å°¿öµå
Bladder cancer;Cyclooxygenase-2;Survivin
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸